We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

By LabMedica International staff writers
Posted on 27 Mar 2024

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. More...

Other transmission modes include blood transfusions, organ transplants, and shared needles or syringes contaminated with infected blood. Although the largest burden of malaria is in sub-Saharan Africa, Southeast Asia, the Eastern Mediterranean, the Western Pacific, and the Americas also report many cases and deaths. Because of the risk of malaria transmission, many potential blood donors who have traveled to or lived in malaria-endemic areas are currently ineligible to donate blood. The existing methods for detecting malaria in blood, such as microscopy and serology, lack the necessary sensitivity to ensure the safety of blood transfusions. Now, the first FDA-approved molecular test to screen U.S. blood donors for malaria marks a significant advancement in maintaining a safe global blood supply.

Roche (Basel, Switzerland) has obtained FDA approval for the cobas Malaria test for use on the cobas 6800/8800 Systems. This test enables healthcare providers to minimize the risks of malaria transmission through blood transfusion by identifying blood units infected with malaria. It screens for the five primary species of Plasmodium parasites that cause malaria in humans, enhancing both the safety and availability of blood supplies. Designed for screening blood, organs, and tissue donations, the cobas Malaria test is a qualitative in vitro test that detects Plasmodium RNA and DNA in whole blood samples from individual donors. It is essential to note that the test is not for diagnosing Plasmodium infections, nor is it applicable to cord blood samples or cadaveric blood specimens. Utilizing the Roche Whole Blood Collection Tube, the test streamlines the workflow by allowing direct blood draws from donors and immediate processing on the cobas 6800/8800 Systems.

“As the first FDA-approved blood screening test for malaria, this represents an important step forward in safeguarding the global supply of donated blood," said Matt Sause, CEO of Roche Diagnostics. “The approval of cobas Malaria represents a significant advancement in malaria detection, offering healthcare professionals a reliable tool for donor screening and improving the safety of patients worldwide.”


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.